Services search (in the department)
Illness | Number of cases |
---|---|
Other disorders of nose and nasal sinuses - Deviated nasal septum (J34.2) | 30 |
Chronic diseases of tonsils and adenoids - Hypertrophy of adenoids (J35.2) | 13 |
Acute sinusitis (J01.0) | not specified |
Chronic sinusitis - Chronic maxillary sinusitis (J32.0) | not specified |
Chronic diseases of tonsils and adenoids (J35.0) | not specified |
Treatment | Number |
---|---|
Surgical removal or reconstruction of the nasal septum (5-214.70) | 17 |
Operation on the inferior nasal concha (5-215.2) | 16 |
Surgical removal of the (enlarged) adenoids (without removal of the tonsils) (5-285.0) | 16 |
Surgical removal or reconstruction of the nasal septum (5-214.6) | 15 |
Surgical incision into the eardrum (tympanic membrane) (5-200.5) | 5 |
Operation on the inferior nasal concha (5-215.1) | 5 |
Surgical removal of the palatine tonsils (without removal of the adenoids) - tonsillectomy without adenoidectomy (5-281.5) | 5 |
Operation on the maxillary sinuses (5-221.6) | 4 |
Surgical incision into the eardrum (tympanic membrane) (5-200.4) | 0 |
Surgical removal or reconstruction of the nasal septum (5-214.0) | 0 |
Department key: 2600
Inpatient department
No. | Explanation |
---|---|
CQ06 | |
CQ01 |
Number | Group |
---|---|
165 | Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training* |
90 | Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence |
75 | Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations |
Job | Explanation |
---|---|
Lectureships / teaching posts at universities of applied sciences | |
Doctoral supervision | |
Initiation and management of uni-centric/multi-centric clinical/scientific studies | |
Participation in multi-centre phase III/IV studies | ALTTO- Follow-Up (im Rahmen des HBZ) HD 21 Hodgkin Lymphom, ESCALADE bei B-Cell Lymphoma, CZAR-I, PREPARE 2.0 bei Nierenzellkarzinom, CIRCULATE bei Darmkrebs Stage II, NIS: Lungen carcinom CLL, CML, Nieren Ca. |
Lectureships / teaching posts at colleges and universities | |
Student training (clinical traineeship / internship year) | In Zusammenarbeit mit dem Universitätsklinikum Hamburg Eppendorf UKE und dem Universitätsklinikum Schleswig-Holstein - Campus Kiel. |
Project-related cooperation with colleges and universities | Hochschulstandort Neumünster |
Participation in multi-centre Phase I/II studies | PanaMa Studie für Metastatic colorectal cancer, FOOTPATH Studie für metastatic pancreatic cancer., Alternative C Phase II, GOAL II |
Editors of scientific journals/textbooks |
No. | Training in other healing professions | Comment |
---|---|---|
HB17 | Auxiliary nurse (m/f) | 25 Ausbildungsplätze |
HB03 | Physical therapist / physiotherapist (m/f) | Absolvierung des obligatorischen Praktikums im FEK. |
HB06 | Occupational therapist (m/f) | Absolvierung des obligatorischen Praktikums im FEK |
HB05 | Medical technical radiology assistant (MTRA) (m/f) | Absolvierung des obligatorischen Praktikums im FEK |
HB12 | Medical technical laboratory assistant (MTLA) (m/f) | Absolvierung des obligatorischen Praktikums im FEK |
HB16 | Dietician (m/f) | Absolvierung des obligatorischen Praktikums im FEK |
HB10 | Midwife (m/f) | Absolvierung des obligatorischen Praktikums im FEK |
HB13 | Medical technical assistant for functional diagnostics (MTAF) (m/f) | Absolvierung des obligatorischen Praktikums im FEK |
HB09 | Speech therapist (m/f) | Absolvierung des obligatorischen Praktikums im FEK |
HB07 | Surgical technical assistant (m/f) | |
HB01 | Nurse and health care worker (m/f) | Im 2021 waren 37 Ausbildungsplätze im Kurs 19/22 belegt, der in 2022 abschlossen hat. Einen Neustart für diese Ausbildung wird es nicht mehr geben. |
HB15 | Anaesthesia technical assistant (m/f) | |
HB19 | Nursing professionals | 65 Ausbildungsplätze |
Andrea Vollert
Leitung Stabsstelle Qualitäts- und Risikomanagement
Phone:
04321
-405-1004
Mail:
ed.kef@trellov.aerdna
PD Dr. med. Andrea Pace
Ärztlicher Direktor, Chefarzt Gastroenterologie
Phone:
04321
-405-7041
Mail:
ed.kef@ecap.aerdna
Malte Dobin
Leitung Apotheke / Ansprechpartner Arzneimitteltherapiesicherheit
Phone:
04321
-405-3600
Mail:
ed.kef@nibod.etlam